LifeStance Health Group, Inc. (NASDAQ: LFST) reported Q4 net loss of $108 million. Revenue for the quarter came in at $190.1 million versus the consensus estimate of $191.69 million.

GUIDANCE:

LifeStance Health Group, Inc. sees FY2022 revenue of $865-885 million, versus the consensus of $875 million.

For earnings history and earnings-related data on LifeStance Health Group, Inc. (LFST) click here.